We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$338B
AUM Growth
+$13.2B
(+4.1%)
Cap. Flow
-$8.05B
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
23.21%
Holding
3,478
New
75
Increased
881
Reduced
2,243
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$3.24B |
| 2 |
Palo Alto Networks
PANW
|
+$489M |
| 3 |
Tesla
TSLA
|
+$372M |
| 4 |
Qualcomm
QCOM
|
+$361M |
| 5 |
Broadcom
AVGO
|
+$351M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.18B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$662M |
| 3 |
Amazon
AMZN
|
+$544M |
| 4 |
Apple
AAPL
|
+$540M |
| 5 |
Meta Platforms (Facebook)
META
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.36% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 12.26% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Stoke Therapeutics
STOK
$2.11B
| $1.02M | ﹤0.01% |
57,157
-4,672
| -8% | -$111K |
|
2852
Xometry
XMTR
$5.34B
| $1.02M | ﹤0.01% |
24,281
-2,342
| -9% | -$120K |
|
2853
Tredegar Corp
TG
$310M
| $1.01M | ﹤0.01% |
91,726
-8,579
| -9% | -$103K |
|
2854
Caribou Biosciences
CRBU
$164M
| $1.01M | ﹤0.01% |
62,781
-3,007
| -5% | -$58.5K |
|
2855
Avalo Therapeutics
AVTX
$983M
| $1.01M | ﹤0.01% |
206
-6
| -3% | -$36K |
|
|
XXII
2856
22nd Century Group
XXII
$1.48M
| – | – |
0
| – | – |
|
2857
Aligos Therapeutics
ALGS
$34.9M
| $1M | ﹤0.01% |
3,371
-158
| -4% | -$57.6K |
|
|
IMA
2858
ImageneBio Inc
IMA
$64.6M
| $997K | ﹤0.01% |
6,066
+3,309
| +120% | +$537K |
|
|
IHC
2859
DELISTED
Independence Holding Company
IHC
| $995K | ﹤0.01% |
17,572
-4,294
| -20% | -$229K |
|
2860
South Plains Financial
SPFI
$841M
| $993K | ﹤0.01% |
37,196
-3,255
| -8% | -$84.7K |
|
2861
Commercial Vehicle Group
CVGI
$147M
| $992K | ﹤0.01% |
132,676
+10,021
| +8% | +$90.7K |
|
2862
NVE Corp
NVEC
$609M
| $991K | ﹤0.01% |
15,462
-2,045
| -12% | -$140K |
|
|
AMTI
2863
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $988K | ﹤0.01% |
73,287
-6,333
| -8% | -$125K |
|
|
PVBC
2864
DELISTED
Provident Bancorp
PVBC
| $986K | ﹤0.01% |
54,255
-7,340
| -12% | -$132K |
|
2865
Astronics
ATRO
$3.84B
| $978K | ﹤0.01% |
116,288
-7,084
| -6% | -$74.4K |
|
|
ITIC
2866
Investors Title Co
ITIC
$547M
| $975K | ﹤0.01% |
4,499
-414
| -8% | -$85.9K |
|
|
RPT
2867
Rithm Property Trust
RPT
$93.7M
| $962K | ﹤0.01% |
12,585
-1,072
| -8% | -$87.5K |
|
2868
Aviat Networks
AVNW
$273M
| $958K | ﹤0.01% |
31,756
-2,669
| -8% | -$83.4K |
|
2869
XBiotech
XBIT
$69.2M
| $957K | ﹤0.01% |
85,962
+15,546
| +22% | +$202K |
|
|
SMMF
2870
DELISTED
Summit Financial Group, Inc.
SMMF
| $957K | ﹤0.01% |
36,161
-3,057
| -8% | -$80.8K |
|
2871
Quince Therapeutics
QNCX
$29.5M
| $954K | ﹤0.01% |
378
-26
| -6% | -$159K |
|
2872
Rocky Brands
RCKY
$369M
| $954K | ﹤0.01% |
26,498
-2,321
| -8% | -$100K |
|
|
TRHC
2873
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $950K | ﹤0.01% |
68,317
-5,488
| -7% | -$99.9K |
|
2874
Eos Energy Enterprises
EOSE
$1.51B
| $949K | ﹤0.01% |
124,390
+3,207
| +3% | +$32.6K |
|
2875
iShares Russell 1000 ETF
IWB
$50.1B
| $942K | ﹤0.01% |
3,563
+1,321
| +59% | +$340K |
|
Similar funds
VFT
Nuveen's Q4 2021 Portfolio in Review
As of Q4 2021, Nuveen held 3,478 positions worth $338B, up 4.1% from $325B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q4 2021 filing shows 75 new, 881 increased, 2,243 reduced and 162 closed positions. Its largest new stake was Roblox: 1,368,944 shares worth $141M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Nuveen's largest Q4 2021 buy was Roblox: 1,368,944 shares worth $141M.
- Nuveen added most to Nuveen Growth Opportunities ETF in Q4 2021, an estimated $3.24B increase.
- Nuveen's biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.18B.
- Nuveen fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $102M.
- Nuveen's ten largest holdings make up 23% of its $338B portfolio in Q4 2021.
- Nuveen opened 75 new positions and closed 162 in Q4 2021.
- Nuveen's portfolio value rose 4.1% quarter-over-quarter to $338B.
Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.